Drug discovery and development is offered as a concentration within the professional science master's program described under
Business and Science 137
.
The objective of the master of business and science degree with a
concentration in drug discovery and development is to provide
broad-based training for students in the area of drug discovery, drug
development, regulatory affairs, and clinical trials management.
Students will learn about the workings of the pharmaceutical development
process and will acquire analytical and communication skills suitable
for managerial and staff positions in laboratory and clinical research,
clinical trials, contract research organizations, federal agencies for
regulatory affairs (e.g., the Food and Drug Administration), and
pharmaceutical marketing.
All students in the drug discovery and development concentration must take the following courses:
16:115:512 Molecular Biology and Biochemistry (3) or 16:148:514
Molecular Biology of Cells (3)
16:137:510 Drug Development from
Concept to Market (3) or 16:137:501 Fundamentals of Intellectual
Property (3)
16:137:511 Drug Discovery through Preclinical Development (3)
16:137:580 Practical Aspects of Clinical Trial Design/Conduct (3)
16:137:581 Statistics in Clinical and Translational Research (3)
16:137:583 Ethics and Regulations in Clinical Research (3)
Course descriptions and electives can be found at http://psm.rutgers.edu.
Concentration Coordinator:
Professor Sangya Varma
sangya@rci.rutgers.edu
|
